Landing
Retina Society 2024
Update on Pegcetacoplan for Geographic Atrophy: Clinical Studies and Real–World Experience
Pegcetacoplan vs Avacincaptad Pegol in Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of Three Phase 3 Trials Over 24 Months
Beneficial Effects in Macular Function with Continuous Pegcetacoplan Treatment: OAKS, DERBY, and GALE Open-Label Extension
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.